Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading
-
Business10 hours agoSilver reaches a 14-year high. Will it outperform the gold price this year?
-
Business15 hours agoWhere I’d invest $5,000 into ASX dividend shares right now
-
Business12 hours ago$20,000 in savings? Here’s how to target $1,000 of passive income each month
-
General19 hours agoUK police drop Kneecap investigation over Glastonbury set